Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. - Morgan,B.; Thomas,A.L.; Drevs,J.; Hennig,J.; Buchert,M.; Jivan,A.; Horsfield,M.A.; Mross,K.; Ball,H.A.; Lee,L.; Mietlowski,W.; Fuxuis,S.; et al. (J Clin Oncol, 2003)